Yadav Renu Kumari, Singh Gagandeep, Kiran Kvp Sai, Iram Azka, Rana Bhaskar, Cs Saumya, Xess Immaculata
AIIMS, New Delhi, India.
Indian J Med Microbiol. 2023 Mar-Apr;42:25-29. doi: 10.1016/j.ijmmb.2022.12.014. Epub 2023 Jan 20.
Candida albicans is the major cause of fungal UTI in neonates and infants but nowadays non albicans Candida is also increasing and these are mostly multidrug resistant. So it's important to know the species of candidal UTI for the proper management. This study was undertaken to determine the Candida species distribution in UTI along with their susceptibility pattern and outcome in infants and neonates admitted in different wards and ICU of our hospital. We also assess the incidence rate of candiduria in ICUs.
Urine samples were collected from infants and neonates presented in pediatrics and neonatal ICU (intensive care units) and clinical wards with a clinical suspicion of candiduria and infants at risk of invasive candidiasis were also included in the study. Identification of Candida sp. was done by Gram's staining, germ tube test, chlamydospore formation on corn meal agar, color appearance on CHROM agar and also confirmed by MALDI-TOF Assay. Antifungal susceptibility was performed by using broth microdilution method as per the CLSI M27-A3/M27-S4.
Urine samples were received from 219 infants, and Candida was isolated from samples from 52 infants (isolation rate 23.75%), of which 30 were admitted in pediatric or neonatal ICU and 22 in the wards. The incidence rate of candiduria in ICU was 3.25%. Candida albicans was the most frequently isolated species from the samples of infants in the wards (13/22 i.e. 59%), while Candida tropicalis was most frequently isolated from samples of infants in the ICUs (13/30 i.e. 43.34%). Candida glabrata was the least commonly isolated species and was only encopuntered in the ICU. There was no discrepancy between the results of conventional methods of identification and MALDI-TOF. Antifungal susceptibility was performed for 18 randomly selected isolates. All were found to be susceptible to caspofungin, micafungin, itraconazole, voriconazole, fluconazole, amphotericin B.
High suspicion of candiduria is needed especially in ICU admitted infants and identification of candida at species level along with the susceptibility pattern is important for the better management of patients.
白色念珠菌是新生儿和婴儿真菌性尿路感染的主要病因,但如今非白色念珠菌也在增加,且大多具有多重耐药性。因此,了解念珠菌性尿路感染的菌种对于正确治疗很重要。本研究旨在确定我院不同病房和重症监护病房(ICU)收治的婴儿和新生儿尿路感染中念珠菌的菌种分布及其药敏模式和治疗结果。我们还评估了ICU中念珠菌尿的发病率。
从儿科、新生儿ICU以及临床病房中临床怀疑有念珠菌尿的婴儿和新生儿中收集尿液样本,研究还纳入了有侵袭性念珠菌病风险的婴儿。念珠菌属的鉴定通过革兰氏染色、芽管试验、玉米粉琼脂上的厚壁孢子形成、CHROM琼脂上的颜色外观进行,并且通过基质辅助激光解吸电离飞行时间质谱分析(MALDI-TOF分析)进行确认。根据美国临床和实验室标准协会(CLSI)M27-A3/M27-S4采用肉汤微量稀释法进行抗真菌药敏试验。
共收到219名婴儿的尿液样本,52名婴儿的样本中分离出念珠菌(分离率23.75%),其中30名入住儿科或新生儿ICU,22名入住病房。ICU中念珠菌尿的发病率为3.25%。白色念珠菌是病房中婴儿样本中最常分离出的菌种(13/22,即59%),而热带念珠菌是ICU中婴儿样本中最常分离出的菌种(13/30,即43.34%)。光滑念珠菌是最不常分离出的菌种,仅在ICU中发现。传统鉴定方法与MALDI-TOF的结果之间没有差异。对18株随机选择的分离株进行了抗真菌药敏试验。发现所有分离株对卡泊芬净、米卡芬净、伊曲康唑、伏立康唑、氟康唑、两性霉素B均敏感。
尤其是对于入住ICU的婴儿,需要高度怀疑念珠菌尿,并且在菌种水平上鉴定念珠菌及其药敏模式对于更好地治疗患者很重要。